<DOC>
	<DOC>NCT01010191</DOC>
	<brief_summary>Irritable bowel syndrome patients will be given either placebo pill or no treatment for a period of 3 weeks.</brief_summary>
	<brief_title>Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS)</brief_title>
	<detailed_description>Seventy patients with irritable bowel syndrome (IBS) will be randomized to either 1) placebo pill or 2) no treatment and followed for 3 weeks. The study will involve three visits: baseline, midpoint and end point. At baseline all patients will physical examination, be evaluated for IBS and be administered standardized IBS questionnaires including: "IBS adequate relief" questionnaire, IBS global symptom improvement scale, IBS quality of life and IBS symptom severity scale. At midpoint and endpoint the same questionnaires will be administered. Patients on no treatment will be offered education on managing IBS at the end of the study.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Irritable bowel syndrome. Any signs of organic bowel disease such as rectal bleeding. No other major illnesses.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>irritable bowel syndrome</keyword>
	<keyword>no organic digestive disease</keyword>
</DOC>